Clinical trials
Ischemia trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 4 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rigshospitalet, Denmark | 3 |
| Odense University Hospital | 2 |
| University of Aarhus | 2 |
| University of Copenhagen | 2 |
| Aarhus University Hospital | 1 |
| Aarhus University Hospital Skejby | 1 |
| Abbott Medical Devices | 1 |
| Biotronik AG | 1 |
| Diagram B.V. | 1 |
| Hvidovre University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemia | 19 |
| Coronary Artery Disease | 5 |
| Myocardial Ischemia | 4 |
| Stroke | 3 |
| Vascular Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Heart Diseases | 2 |
| Acute Coronary Syndrome | 1 |
| Agnosia | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.